Opinion|Videos|August 23, 2024
Biosimilar Utilization and Inventory Management
Author(s)Sophia Humphreys, PharmD, MHA
Sophia Humphreys, PharmD, MHA, BCBBS, discusses biosimilar utilization and inventory management.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How has the introduction of biosimilars affected the biologic landscape at specialty pharmacies, including the disease states treated and trends in utilization?
- What strategies, including the “just in time” inventory model, can specialty pharmacies employ to effectively manage their high-cost biologic and biosimilar inventory given the challenges of limited shelf space?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
World Schizophrenia Day: One Pharmacist's Vision for Safer Schizophrenia Care
2
Hepatitis B Is Still Active: What Pharmacists Need to Know About Adult Transmission Rates and Vaccine Gaps
3
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer?
4
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
5